Main methods Assessment included magnesium sulfate (560 mg/kg intraperitoneally)-induced muscle weakness, muscle and brain lesions, hypermagnesemia, hyperkalaemia, increased serum enzyme values assessed in rats during and at the end of a 30-min period and medication (given intraperitoneally/kg at 15 min before magnesium) [BPC 157 (10 g, 10 ng), l-NAME (5 mg), l-arginine (100 mg), alone and/or together]
Ensuring adequate electrolyte intake matters too, since peptide protocols sometimes coincide with dietary changes that affect mineral balance
These changes usually begin as medication levels decline, with timing varying based on the drug's half-life
Independent lab results available on request You're protected by the Curex guarantee
Researchers recommend incorporating detailed dietary monitoring, microbiome profiling, and symptom tracking in future trials